These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 280261)

  • 41. Cooperativity in inhibition of coupled and uncoupled respiration in rat liver and brain mitochondria by imipramine.
    Rajan RR; Katyare SS
    Indian J Biochem Biophys; 1985 Apr; 22(2):71-7. PubMed ID: 2933326
    [No Abstract]   [Full Text] [Related]  

  • 42. Calcium efflux and respiratory inhibition in brain mitochondria: effects of chlorpromazine metabolites.
    Tjioe SA; Manian AA; O'Neill JJ
    Biochem Biophys Res Commun; 1972 Jul; 48(1):212-8. PubMed ID: 5041878
    [No Abstract]   [Full Text] [Related]  

  • 43. Accumulation of adenosine cyclic 3',5'-monophosphate in rat cerebral cortical slices. Stimulatory effect of alpha and beta adrenergic agents after treatment with 6-hydroxydopamine, 2,3,5-trihydroxyphenethylamine, and dihydroxytryptamines.
    Huang M; Ho AK; Daly JW
    Mol Pharmacol; 1973 Nov; 9(6):711-7. PubMed ID: 4148652
    [No Abstract]   [Full Text] [Related]  

  • 44. Release of mitochondrial respiratory control by cyanate salts.
    Cammer W
    Biochim Biophys Acta; 1982 Feb; 679(2):343-6. PubMed ID: 7059586
    [No Abstract]   [Full Text] [Related]  

  • 45. The potential neurotoxin 2-OH-dopamine is an inhibitor of arylsulfatase.
    Cawley TA; Shickley TJ
    Ann N Y Acad Sci; 1992 May; 648():256-9. PubMed ID: 1353330
    [No Abstract]   [Full Text] [Related]  

  • 46. Effect of central catecholamine depletions by 6-hydroxydopamine on morphine antinociception in rats.
    Elchisak MA; Rosecrans JA
    Res Commun Chem Pathol Pharmacol; 1973 Jul; 6(1):349-52. PubMed ID: 4734013
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of central early postnatal 6-hydroxydopamine administration on brain catecholamines and pituitary-adrenal function in adulthood.
    Kaplanski J; Nyakas C; van Delft AM; Smelik PG
    Neuroendocrinology; 1973-1974; 13(1):123-7. PubMed ID: 4779045
    [No Abstract]   [Full Text] [Related]  

  • 48. Bioactive Oleic Derivatives of Dopamine: A Review of the Therapeutic Potential.
    Pokorski M; Zajac D
    Adv Exp Med Biol; 2018; 1096():73-82. PubMed ID: 29623573
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The influence of electron transport chain inhibitors on mature rate brain mitochondria.
    Milstein JM; Swaiman KF
    Neurology; 1968 Mar; 18(3):297-8. PubMed ID: 5690392
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of gangliosides on the active transport of Ca++ in brain mitochondria].
    Mikheyan EY; Sotski OP
    Vopr Biokhim Mozga; 1970; 6():213-8. PubMed ID: 5526456
    [No Abstract]   [Full Text] [Related]  

  • 51. [Experimental study for the spasmodic torticollis-like posture by chemical lesioning in the ventromedial tegmentum (VMT) in cats (author's transl)].
    Kawano T
    No To Shinkei; 1979 Jul; 31(7):679-85. PubMed ID: 497055
    [No Abstract]   [Full Text] [Related]  

  • 52. Serotonin neurotoxins: recent advances in the mode of administration and molecular mechanism of action.
    Baumgarten HG; Jenner S; Klemm HP
    J Physiol (Paris); 1981; 77(2-3):309-14. PubMed ID: 7288647
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mechanism of action of dihydroxytryptamines.
    Creveling CR; Rotman A
    Ann N Y Acad Sci; 1978 Jun; 305():57-73. PubMed ID: 280257
    [No Abstract]   [Full Text] [Related]  

  • 54. Differential susceptibility of mice humanized for peroxisome proliferator-activated receptor alpha to Wy-14,643-induced liver tumorigenesis.
    Morimura K; Cheung C; Ward JM; Reddy JK; Gonzalez FJ
    Carcinogenesis; 2006 May; 27(5):1074-80. PubMed ID: 16377806
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immediate and long-term effects of 5,7-dihydroxytryptamine on rat striatal serotonergic neurons measured using in vivo voltammetry.
    Nakazato T; Akiyama A
    Neurochem Res; 1998 Jan; 23(1):1-6. PubMed ID: 9482260
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of neurocatin on the activity of monoamine oxidase B in rat brain synaptosomes.
    Murphy S; Pastuszko A
    Neurochem Res; 1994 Feb; 19(2):177-82. PubMed ID: 8183427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Peroxidase-promoted oxidation and peroxidation of the serotonergic neurotoxin 5,7-dihydroxytryptamine. A new pathway for its metabolic degradation.
    Metodiewa D; Dunford HB
    Mol Cell Biochem; 1992 May; 112(1):35-44. PubMed ID: 1513333
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mechanisms of action of hydroxylated phenylethylamine and indoleamine neurotoxins.
    Cohen G; Heikkila RE
    Ann N Y Acad Sci; 1978 Jun; 305():74-84. PubMed ID: 280261
    [No Abstract]   [Full Text] [Related]  

  • 59. Asymmetric action of intraventricular monoamine neurotoxins.
    Gershanik OS; Heikkila RE; Duvoisin RC
    Brain Res; 1979 Oct; 174(2):345-50. PubMed ID: 487133
    [No Abstract]   [Full Text] [Related]  

  • 60. The biochemical and pharmacological properties of 6-aminodopamine: similarity with 6-hydroxydopamine.
    Heikkila RE; Mytilineou C; Côté LJ; Cohen G
    J Neurochem; 1973 Jul; 21(1):111-6. PubMed ID: 4720889
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.